The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Ambrosio, D.
Right arrow Articles by Sinigaglia, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Ambrosio, D.
Right arrow Articles by Sinigaglia, F.
The Journal of Immunology, 1998, 161: 5111-5115.
Copyright © 1998 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: Selective Up-Regulation of Chemokine Receptors CCR4 and CCR8 upon Activation of Polarized Human Type 2 Th Cells1

Daniele D’Ambrosio2,*, Andrea Iellem*, Raffaella Bonecchi{dagger}, Daniela Mazzeo*, Silvano Sozzani{dagger}, Alberto Mantovani{dagger} and Francesco Sinigaglia*

* Roche Milano Ricerche, Milan, Italy; and {dagger} Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Polarized Th1 and Th2 cells differentially express adhesion molecules and chemokine receptors, endowing these cells with distinct tissue homing capabilities. Here we report that, in contrast to other chemokine receptors, the expression of CCR4 and CCR8 on Th2 cells is transiently increased following TCR and CD28 engagement. IL-4 is not required for this activation-induced up-regulation of CCR4 and CCR8. In accordance with receptor expression, the response of Th2 cells to I-309 (CCR8 ligand) and thymus- and activation-regulated chemokine (CCR4 and CCR8 ligand) is enhanced upon activation. Moreover, activated Th1 cells up-regulate CCR4 expression and functional responsiveness to thymus- and activation-regulated chemokine. Analysis of polarized subsets of CD8+ T cells reveals a similar pattern of chemokine receptor expression and modulation of responsiveness. Taken together, these findings suggest that an up-regulation of CCR4 and CCR8 following Ag encounter may contribute to the proper positioning of activated T cells within sites of antigenic challenge and/or specialized areas of lymphoid tissues.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
The differentiation process of CD4+ T cells proceeds along two distinct pathways leading to the generation of polarized effector Th cells (1, 2, 3). IFN-{gamma}-producing Th1 cells promote phagocyte-dependent immunity (4, 5). Th2 cells secreting IL-4 and IL-5 promote IgE production and allergic responses (6). Similar to the generation of CD4+ Th1 and Th2 cells, naive CD8+ T cells can differentiate into Th1 type 1 cytotoxic CD8+ T cells (Tc1)3 cells or Tc2 type cytotoxic CD8+ T cells (7).

A multistep process mediated by the interplay of adhesion molecules and chemokines that involves rolling, firm adhesion, and diapedesis results in the extravasation of immune effector cells within peripheral tissues (8, 9). Recent findings indicate that P- and E-selectin ligands (10) and chemokine receptors (11, 12) are differentially expressed on Th1 and Th2 cells, providing these cells with distinct tissue-homing abilities (13). Chemokines are members of a large family of small cytokines that play a key role in the leukocyte-recruitment process (14, 15, 16). We and others have reported recently that among eight CC and four CXC chemokine receptors, Th1 cells predominantly express CXCR3 and CCR5 (12, 17, 18); Th2 cells selectively express CCR3 (11), CCR4 (12, 17), and CCR8 (19). Although these findings suggest that different chemotactic signals are required for extravasation, migration, and tissue homing, the hierarchy and composition of these signals are unknown and may depend upon the chemokines present in the tissue and the chemokine receptors expressed on the invading cells.

Here, we investigated the effect of Ag receptor triggering on the expression pattern of chemokine receptors on Th1 and Th2 cells. Our data indicate that, in contrast to other chemokine receptors, the expression of CCR4 and CCR8 on Th2 cells and CCR4 on Th1 cells is markedly increased upon activation. These findings suggest a unique role for these receptors in extravasation, tissue migration, and the positioning of effector T cells.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Type 1 and type 2 lines and Th2 cell clones

Type 1 and type 2 cell lines were generated from cord blood lymphocytes and maintained in culture as described previously (20). CD4+ Th1 and Th2 cells and CD8+ Tc1 and Tc2 cells were purified by immunomagnetic negative selection using anti-CD4 or anti-CD8 mAb-coated microbeads according to the manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). The Lolium perenne group-1-specific Th2 clone D4.11, which was obtained as described previously (12), was restimulated with PHA and irradiated PBMCs and cultured in complete medium with IL-2.

Northern blot analysis

For Northern blots, total RNA was extracted from polarized CD4+ or CD8+ T cells by TRIzol (Life Technologies, Grand Island, NY). For activation experiments, purified CD4+ Th1 and Th2 cells were either left untreated or incubated for 16–24 h on anti-CD3 (Tr66 mAb)-coated plates with 1 µg/ml of anti-CD28 mAb (PharMingen, San Diego, CA). The Th2 clone D4.11 was either left untreated or incubated for 24 h on anti-CD3-coated plates with 1 µg/ml of anti-CD28 mAb. TCR triggering was terminated by washing and culturing the cells in complete medium with IL-2. Untreated and TCR-stimulated cells were lysed at various times after the termination of TCR-triggering. Total RNA was extracted, and equal amounts of RNA (10 µg/lane) were fractionated on a 1% agarose-formaldehyde gel. The specific mRNAs were detected by the hybridization of nylon membranes (NorthernMax Kit, Ambion, Austin, TX) with 32P-labeled DNA probes for human CCR3, CCR4, CCR5, CCR8, and CXCR3 according to the manufacturer’s instructions (NorthernMax Kit, Ambion). The filters were exposed to X-OMAT AR film (Eastman Kodak, Rochester, NY) between double intensifying screens (DuPont, San Diego, CA) at -70°C. The extent of the hybridization was quantified by densitometric analysis with the entry level image system (Immagini e computer, Milan, Italy), and the values were normalized using the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signal as a reference.

Analysis of intracellular calcium mobilization

Type 1 and type 2 polarized T cells were either left untreated or activated as described above. Next, cells were washed and rested by incubation in complete medium with IL-2 for 12 h. Fluo-3/acetoxymethyl ester (AM) loading (21) was performed by incubating the cells (5 x 106/ml) in buffer A (HBSS with 10 mM HEPES) with 2 µM fluo-3/AM (Molecular Probes, Eugene, OR) at 37°C for 30 min. The incubation was prolonged by 30 min after the addition of an equal volume of buffer B (HBSS with 10 mM HEPES and 5% FCS). Cells were washed twice in buffer B and stained with quantum red-conjugated anti-CD4 or anti-CD8 Abs (Sigma, St. Louis, MO). Cells were washed, resuspended at 2 x 106/ml, and analyzed by FACS. Emissions at 525 and 613 nm were measured on a log scale before and after stimulation with the chemokines (IFN-inducible protein-10 (IP-10), eotaxin, I-309, and thymus- and activation-regulated chemokine (TARC) were purchased from R&D Systems, Minneapolis, MN). Analysis was restricted to CD4+ or CD8+ T cells by gating on FL3+ cells, with an acquisition of 3000 events.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
To study the regulation of chemokine receptor expression on Th cells, we generated T cell lines from leukocytes isolated from cord blood as described previously (20). The Th phenotype of CD4+ and CD8+ T cells was determined by restimulation and intracellular staining for IFN-{gamma} and IL-4 production (data not shown). Purified CD4+ Th1 or Th2 cells were either left in culture with IL-2 or cultured on anti-CD3 mAb-coated plates with soluble anti-CD28 mAb. Subsequently, the cells were lysed, and total RNA was extracted and analyzed for CXCR3, CCR3, CCR4, and CCR8 mRNA expression. In agreement with recent reports (11, 12, 18, 19), CXCR3 is preferentially expressed on Th1 cells, whereas CCR3, CCR4, and CCR8 are preferentially expressed on Th2 cells (Fig. 1GoA). Stimulation with anti-CD3 and anti-CD28 Abs down-regulates the mRNA expression of CXCR3 in Th1 cells and CCR3 in Th2 cells (Fig. 1GoA). In contrast, CCR4 and, to a greater extent, CCR8 transcripts are up-regulated in TCR-stimulated Th2 cells (Fig. 1GoA). In addition, CCR4 mRNA becomes detectable in TCR-stimulated Th1 cells (Fig. 1GoA).



View larger version (31K):
[in this window]
[in a new window]
  		FIGURE 1. Activation-dependent regulation of chemokine receptor expression in Th1 and Th2 cells. A, Th1 and Th2 cells were either left untreated or cultured on anti-CD3 mAb-coated plates with soluble anti-CD28 mAb. Cells were harvested, and total RNA was extracted. A total of 10 µg of total RNA was subsequently used in Northern blot analysis. Filters were hybridized with 32P-labeled probes for CXCR3, CCR3, CCR4, and CCR8. Equivalent loading of RNA was verified by ethidium bromide staining of 18S and 28S ribosomal RNA. B, Th2 cells were either left untreated or cultured on anti-CD3 mAb-coated plates with soluble anti-CD28 mAb in the presence or absence of anti-IL-4 mAb (500 ng/ml). A total of 10 µg of total RNA was subsequently used in Northern blot analysis. Filters were hybridized with 32P-labeled probes for CCR4, CCR8, and GAPDH.

 
Since CCR4 and CCR8 are expressed on Th2 cells that have been generated in vitro in the presence of IL-4, it is possible that the IL-4 produced upon restimulation of Th2 cells is responsible for the increased expression of CCR4 and CCR8. Therefore, we performed the stimulation in the presence of anti-IL-4 blocking Abs. This experiment shows that blocking IL-4 does not inhibit the up-regulation of CCR4 and CCR8 upon activation of Th2 cells (Fig. 1GoB). Moreover, the addition of exogenous IL-4 or supernatants obtained from activated Th2 cells does not result in an up-regulation of CCR4 and/or CCR8 in Th1 cells or a further enhancement of these receptors in Th2 cells (data not shown).

To test the functional relevance of these observations, we explored chemokine responsiveness by measuring intracellular calcium mobilization following activation of Th1 and Th2 cells. Consistent with receptor expression, Th1 cells preferentially respond to IP-10 (CXCR3 ligand (22)), whereas Th2 cells selectively respond to eotaxin (CCR3 ligand (23)), I-309 (CCR8 ligand (24)), and TARC (CCR4 and CCR8 ligand (25, 26)) (Fig. 2Go). Stimulation with anti-CD3 and anti-CD28 Abs results in diminished responses of Th1 cells to IP-10 (Fig. 2Go, upper left panel) and of Th2 cells to eotaxin (Fig. 2Go, upper right panel). In contrast, the response to TARC and, more markedly, to I-309 is increased upon activation of Th2 cells (Fig. 2Go, middle and lower right panels), and the response to TARC becomes detectable in activated Th1 cells (Fig. 2Go, lower left panel).



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 2. Chemokine-induced intracellular Ca2+ mobilization in resting and activated Th1 and Th2 cells. Th1 and Th2 cells were either left untreated or activated as described in Fig. 1Go. Cells that had been loaded with fluo-3/AM and stained with quantum red-conjugated anti-CD4 Abs were analyzed by flow cytometry by gating on CD4+ cells. Resting (dashed lines) and activated (solid lines) Th1 and Th2 cells were stimulated with IP-10 (50 ng/ml), eotaxin (400 ng/ml), I-309 (200 ng/ml), and TARC (10 ng/ml). The time of the addition of the chemokines is indicated by the arrow. The response is expressed as the fold increase of mean fluorescence intensity at time 0 for emissions at 525 nm. One representative experiment of five is shown.

 
Since the experiments described above were performed on polarized T cell lines obtained by a single cycle of stimulation, we asked whether a T cell clone that had been subjected to repeated cycles of stimulation would exhibit a similar pattern of CCR4 and CCR8 regulation. TCR and CD28 triggering of a Th2 clone results in a marked up-regulation of CCR4 and CCR8 (Fig. 3Go). In addition, following termination of TCR triggering, the expression of CCR4 and CCR8 returns to basal levels within 72 h (Fig. 3Go). Similar findings were observed with cord blood-derived Th2 cells (data not shown). These data indicate that Th2 cells transiently up-regulate CCR4 and CCR8 upon activation via the TCR. Collectively, our findings suggest that TCR-mediated activation of Th cells results in a transient alteration of the pattern of chemokine receptor expression.



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 3. Transient up-regulation of CCR4 and CCR8 expression upon activation of a Th2 clone. The Th2 clone D4.11 was either left untreated or activated as described in Fig. 1Go. A fraction of the cells was lysed immediately (24 h). The remaining cells were washed, cultured, and harvested at 48, 72, and 96 h; total RNA was extracted. A total of 10 µg of total RNA was subsequently used for Northern blot analysis. Filters were hybridized with 32P-labeled probes for CCR4, CCR8, and GAPDH.

 
Previous studies have demonstrated that, in addition to CD4+ T cells, type 1 and type 2 populations of CD8+ T cells (Tc1 and Tc2 cells) can also be generated in vitro and isolated in vivo in immunopathologic conditions (7, 27, 28). Thus, we have extended our analysis of chemokine receptors to polarized Tc1 and Tc2 cells generated from cord blood T cells. An analysis of the mRNA expression of several chemokine receptors revealed that, similar to CD4+ Th cells, Tc1 cells preferentially express CXCR3 and CCR5 (Fig. 4GoA); Tc2 cells selectively express CCR3, CCR4, and CCR8 (Fig. 4GoA). To verify the modulation of chemokine responsiveness upon activation of polarized CD8+ T cells, TCR- and CD28-stimulated Tc1 and Tc2 cells were assayed for their ability to mobilize calcium in response to various chemokines. The overall pattern of calcium mobilization in response to chemokines is concordant with the expression profile of chemokine receptors in Tc1 and Tc2 cells and is similar to Th1 and Th2 cells (Fig. 4GoB and data not shown). The response of Tc1 cells to IP-10 is greatly reduced following TCR-mediated activation (Fig. 4GoB). Activation of Tc2 cells results in a diminished response to eotaxin, whereas the response to TARC and I-309 is increased (Fig. 4GoB). Taken together, these data indicate that the pattern and regulation of chemokine receptor expression of polarized subsets of CD8+ T cells may overlap that of CD4+ T cells.



View larger version (35K):
[in this window]
[in a new window]
  		FIGURE 4. Chemokine receptor expression and modulation of chemokine responsiveness in Tc1 and Tc2 cells. A, A total of 10 µg of total RNA from Tc1 and Tc2 cells was used for Northern blot analysis. Filters were hybridized with 32P-labeled probes for CXCR3, CCR3, CCR4, CCR5, and CCR8. A normalized densitometric analysis of a representative experiment is shown. B, Tc1 and Tc2 cells were either left untreated or activated, loaded with fluo-3/AM, stained with quantum red-conjugated anti-CD8 Abs, and analyzed by flow cytometry by gating on CD8+ cells. Resting (dashed lines) and activated (solid lines) Tc1 and Tc2 cells were stimulated with IP-10 (50 ng/ml), eotaxin (400 ng/ml), I-309 (200 ng/ml), and TARC (10 ng/ml). The time of the addition of the chemokines is indicated by the arrow. The response is expressed as the fold increase of mean fluorescence intensity at time 0 for emissions at 525 nm. One representative experiment of three is shown.

 
Recent studies have reported that TCR-mediated activation of T cells results in a down-modulation of CCR1, CCR2, CCR3, CCR5, and CXCR3 expression (11, 18, 29, 30). Our study reveals that, in contrast to other receptors, CCR4 and, to a greater extent, CCR8 are up-regulated upon TCR-mediated activation of Th2 cells. CXCR4 and CCR7 have been reported to be up-regulated upon activation of T cells (31, 32). However, recent work established that TCR triggering results in a down-modulation of CXCR4 that is subsequently reinduced by the autocrine action of secreted IL-4 (33). Thus, CCR7 is the only other receptor to be up-regulated upon TCR triggering (31). Interestingly, the CCR7 ligands, secondary lymphoid-tissue chemokine, and EBI1 ligand chemokine have been proposed to control the initial entry of naive T cells and the subsequent encounter of activated T and B cells in secondary lymphoid tissues (34, 35). Notably, CCR7 is also up-regulated upon activation of both Th1 and Th2 cells, suggesting a potential contribution to their migration patterns (A.I. and D.D., unpublished observations). Given their mode of regulation, CCR4 and CCR8 may play a role similar to CCR7 in focusing activated T cells to certain areas of lymphoid tissues. However, in contrast to CCR7, CCR4 and particularly CCR8 are selectively expressed on polarized effector Th2 cells, suggesting a unique function in localizing and positioning activated Th2 cells. It is noteworthy that CCR4 and CCR8 share many common features. Their sequence is highly homologous (36, 37); they are both highly expressed on thymocytes, basophils, and Th2 cells (12, 19, 24, 36); and both are receptors for TARC (26). Collectively, these data suggest that CCR4 and CCR8 may play a critical role in localizing activated Th2 cells within sites of antigenic challenge and/or to specialized areas of lymphoid tissues.

Great attention has recently been placed on the possibility of distinguishing Th1 vs Th2 cells on the basis of the differential expression of chemokine receptors. Our findings suggest that CCR8, which is highly expressed upon TCR-mediated activation, may be a very useful and selective marker for the in situ identification of recently activated Th2 cells.


   Acknowledgments
 
We thank M. Napolitano for the CCR8 probe, P. Panina-Bordignon for T cell clones and discussions, and P. Vigano for cord blood samples. We also thank H. Hess and L. Adorini for their critical reading of the manuscript.


   Footnotes
 
1 This work was partially funded by Consiglio Nazionale delle Ricerche Biotecnologie Grant 95-95. Back

2 Address correspondence and reprint requests to Dr. Daniele D’Ambrosio, Roche Milano Ricerche, Via Olgettina 58, Milan, Italy I-20132. E-mail address: Back

3 Abbreviations used in this paper: Tc, cytotoxic CD8+ T cell; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; AM, acetoxymethyl ester; IP-10, IFN-inducible protein-10; TARC, thymus and activation-regulated chemokine. Back

Received for publication August 6, 1998. Accepted for publication September 2, 1998.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, R. L. Coffman. 1986. Two types of murine Th T cell clones: definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.[Abstract]
  2. O’Garra, A., K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.[Medline]
  3. Seder, R. A., W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635.[Medline]
  4. Romagnani, S.. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.[Medline]
  5. Abbas, A. K., K. M. Murphy, A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.[Medline]
  6. Coffman, R. L., T. von der Weid. 1997. Multiple pathways for the initiation of T helper 2 (Th2) responses. J. Exp. Med. 185:373.[Free Full Text]
  7. Seder, R. A., J. L. Boulay, F. Finkelman, S. Barbier, S. Z. Ben-Sasson, G. G. Le Gros, W. E. Paul. 1992. CD8+ T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652.[Abstract]
  8. Springer, T.. 1990. Adhesion receptors of the immune system. Nature 346:425.[Medline]
  9. Butcher, E. C., L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.[Abstract]
  10. Austrup, F., D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, A. Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81.[Medline]
  11. Sallusto, F., C. R. Mackay, A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.[Abstract/Free Full Text]
  12. Bonecchi, R., G. Bianchi, P. Panina-Bordignon, D. D’Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of Th1 and Th2 cells. J. Exp. Med. 187:129.[Abstract/Free Full Text]
  13. Lichtman, A. H., A. K. Abbas. 1997. T-cell subsets: recruiting the right kind of help. Curr. Biol. 7:242.
  14. Mackay, C. R.. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184:799.[Free Full Text]
  15. Hedrick, J. A., A. Zlotnik. 1996. Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8:343.[Medline]
  16. Baggiolini, M., B. Dewald, B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.[Medline]
  17. Sallusto, F., D. Lenig, C. R. Mackay, A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.[Abstract/Free Full Text]
  18. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391:344.[Medline]
  19. Zingoni, A., H. Soto, J. H. Hedrick, A. Stoppacciaro, C. T. Storlazzi, F. Sinigaglia, D. D’Ambrosio, A. O’Garra, D. Robinson, M. Rocchi, A. Santoni, A. Zlotnik, M. Napolitano. 1998. The chemokine receptor CCR8 is preferentially expressed in Th2 cells but not Th1 cells. J. Immunol. 161:547.[Abstract/Free Full Text]
  20. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.[Abstract/Free Full Text]
  21. Kao, J. P. Y., A. T. Harootunian, R. Y. Tsien. 1989. Photochemically generated cytosolic calcium pulses and their detection by Fluo-3. J. Biol. Chem. 264:8179.[Abstract/Free Full Text]
  22. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, B. Moser. 1996. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963.[Abstract/Free Full Text]
  23. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437.[Abstract/Free Full Text]
  24. Tiffany, L. H., L. L. Lautens, J.-L. Gao, J. Pease, M. Locati, C. Combadiere, W. Modi, T. I. Bonner, P. M. Murphy. 1997. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J. Exp. Med. 186:165.[Abstract/Free Full Text]
  25. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272:15036.[Abstract/Free Full Text]
  26. Bernardini, G., W. Luini, G. Spinetti, M. Weiss, S. Menon, A. Zlotnik, A. Mantovani, A. Santoni, M. Napolitano. 1998. Identification of the CC chemokines TARC and macrophage inflammatory protein-1ß as novel functional ligands for the CCR8 receptor. Eur. J. Immunol. 28:582.[Medline]
  27. Sad, S., R. Marcotte, T. R. Mosmann. 1995. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2:271.[Medline]
  28. Maggi, E., M. G. Giudizi, R. Biagiotti, F. Annunziato, R. Manetti, M. P. Piccinni, P. Parronchi, S. Sampognaro, L. Giannarini, G. Zuccati, S. Romagnani. 1994. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:275.
  29. Loetscher, P., M. Seitz, M. Baggiolini, B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.[Abstract/Free Full Text]
  30. Shixin, Q., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746.[Medline]
  31. Burgstahler, R., B. Kempkes, K. Steube, M. Lipp. 1997. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem. Biophys. Res. Commun. 215:737.
  32. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925.[Abstract/Free Full Text]
  33. Jourdan, P., C. Abbal, N. Nora, T. Hori, T. Uchiyama, J.-P. Vendrell, J. Bousquet, N. Taylor, J. Pene, H. Yssel. 1998. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 160:4153.[Abstract/Free Full Text]
  34. Ngo, V. N., L. H. Tang, J. G. Cyster. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 188:181.[Abstract/Free Full Text]
  35. Willimann, K., D. F. Legler, M. Loetscher, R. S. Roos, M. B. Delgado, I. Clark-Lewis, M. Baggiolini, B. Moser. 1998. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 28:2025.[Medline]
  36. Napolitano, M., A. Zingoni, G. Bernardini, G. Spinetti, A. Nista, C. T. Storlazzi, M. Rocchi, A. Santoni. 1996. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J. Immunol. 157:2759.[Abstract]
  37. Power, C. A., A. Meyer, K. Nemeth, K. B. Bacon, J. Hoogewerf, A. E. Proudfoot, T. N. Wells. 1995. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 270:19495.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 BloodHome page
A. Di Stasi, B. De Angelis, C. M. Rooney, L. Zhang, A. Mahendravada, A. E. Foster, H. E. Heslop, M. K. Brenner, G. Dotti, and B. Savoldo
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
Blood, June 18, 2009; 113(25): 6392 - 6402.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H.-B. Kim, C.-K. Kim, K. Iijima, T. Kobayashi, and H. Kita
Protein Microarray Analysis in Patients With Asthma: Elevation of the Chemokine PARC/CCL18 in Sputum
Chest, February 1, 2009; 135(2): 295 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Z. Wiener, P. Pocza, M. Racz, G. Nagy, G. Tolgyesi, V. Molnar, J. Jaeger, E. Buzas, E. Gorbe, Z. Papp, et al.
IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs
Int. Immunol., December 1, 2008; 20(12): 1565 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. S. De Groot, L. Moise, J. A. McMurry, E. Wambre, L. Van Overtvelt, P. Moingeon, D. W. Scott, and W. Martin
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
Blood, October 15, 2008; 112(8): 3303 - 3311.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Zhu and W. E. Paul
CD4 T cells: fates, functions, and faults
Blood, September 1, 2008; 112(5): 1557 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ying, B. O'Connor, J. Ratoff, Q. Meng, C. Fang, D. Cousins, G. Zhang, S. Gu, Z. Gao, B. Shamji, et al.
Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease
J. Immunol., August 15, 2008; 181(4): 2790 - 2798.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Trujillo, E. C. O'Connor, S. L. Kunkel, and C. M. Hogaboam
A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis
Am. J. Pathol., May 1, 2008; 172(5): 1209 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Latzin, D. Hartl, N. Regamey, U. Frey, M. H. Schoeni, and C. Casaulta
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Eur. Respir. J., January 1, 2008; 31(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. W. Lim, J. Lee, P. Hillsamer, and C. H. Kim
Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells
J. Immunol., January 1, 2008; 180(1): 122 - 129.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-A. Gonzalo, Y. Qiu, J. M. Lora, A. Al-Garawi, J.-L. Villeval, J. A. Boyce, C. Martinez-A, G. Marquez, I. Goya, Q. Hamid, et al.
Coordinated Involvement of Mast Cells and T Cells in Allergic Mucosal Inflammation: Critical Role of the CC Chemokine Ligand 1:CCR8 Axis
J. Immunol., August 1, 2007; 179(3): 1740 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Hoshino, Y. I. Kawamura, M. Yasuhara, N. Toyama-Sorimachi, K. Yamamoto, A. Matsukawa, S. A. Lira, and T. Dohi
Inhibition of CCL1-CCR8 Interaction Prevents Aggregation of Macrophages and Development of Peritoneal Adhesions
J. Immunol., April 15, 2007; 178(8): 5296 - 5304.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
T.A. Silva, G.P. Garlet, S.Y. Fukada, J.S. Silva, and F.Q. Cunha
Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease
Journal of Dental Research, April 1, 2007; 86(4): 306 - 319.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Brogdon, Y. Xu, S. J. Szabo, S. An, F. Buxton, D. Cohen, and Q. Huang
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Blood, February 1, 2007; 109(3): 1123 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Fox, P. Najarro, G. L. Smith, S. Struyf, P. Proost, and J. E. Pease
Structure/Function Relationships of CCR8 Agonists and Antagonists: AMINO-TERMINAL EXTENSION OF CCL1 BY A SINGLE AMINO ACID GENERATES A PARTIAL AGONIST
J. Biol. Chem., December 1, 2006; 281(48): 36652 - 36661.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Schnyder-Candrian, D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder
Interleukin-17 is a negative regulator of established allergic asthma
J. Exp. Med., November 27, 2006; 203(12): 2715 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Soler, T. R. Chapman, L. R. Poisson, L. Wang, J. Cote-Sierra, M. Ryan, A. McDonald, S. Badola, E. Fedyk, A. J. Coyle, et al.
CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes
J. Immunol., November 15, 2006; 177(10): 6940 - 6951.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Freeman, V. R. Stolberg, B.-C. Chiu, N. W. Lukacs, S. L. Kunkel, and S. W. Chensue
CCR4 Participation in Th Type 1 (Mycobacterial) and Th Type 2 (Schistosomal) Anamnestic Pulmonary Granulomatous Responses
J. Immunol., September 15, 2006; 177(6): 4149 - 4158.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Montes-Vizuet, A. Vega-Miranda, E. Valencia-Maqueda, M. C. Negrete-Garcia, J. R. Velasquez, and L. M. Teran
CC chemokine ligand 1 is released into the airways of atopic asthmatics
Eur. Respir. J., July 1, 2006; 28(1): 59 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Hartl, P. Latzin, G. Zissel, M. Krane, S. Krauss-Etschmann, and M. Griese
Chemokines Indicate Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1370 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Mikhak, C. M. Fleming, B. D. Medoff, S. Y. Thomas, A. M. Tager, G. S. Campanella, and A. D. Luster
STAT1 in Peripheral Tissue Differentially Regulates Homing of Antigen-Specific Th1 and Th2 Cells.
J. Immunol., April 15, 2006; 176(8): 4959 - 4967.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
P. Najarro, C. Gubser, M. Hollinshead, J. Fox, J. Pease, and G. L. Smith
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.
J. Gen. Virol., April 1, 2006; 87(Pt 4): 809 - 816.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. F. Debes, M. E. Dahl, A. J. Mahiny, K. Bonhagen, D. J. Campbell, K. Siegmund, K. J. Erb, D. B. Lewis, T. Kamradt, and A. Hamann
Chemotactic Responses of IL-4-, IL-10-, and IFN-{gamma}-Producing CD4+ T Cells Depend on Tissue Origin and Microbial Stimulus
J. Immunol., January 1, 2006; 176(1): 557 - 566.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Shigihara, A. Shimada, Y. Oikawa, H. Yoneyama, Y. Kanazawa, Y. Okubo, K. Matsushima, E. Yamato, J.-i. Miyazaki, A. Kasuga, et al.
CXCL10 DNA Vaccination Prevents Spontaneous Diabetes through Enhanced {beta} Cell Proliferation in NOD Mice
J. Immunol., December 15, 2005; 175(12): 8401 - 8408.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. S. Bonder, M. U. Norman, T. MacRae, P. R. Mangan, C. T. Weaver, D. C. Bullard, D.-M. McCafferty, and P. Kubes
P-Selectin Can Support Both Th1 and Th2 Lymphocyte Rolling in the Intestinal Microvasculature
Am. J. Pathol., December 1, 2005; 167(6): 1647 - 1660.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. J. Carpenter and C. M. Hogaboam
Immunosuppressive Effects of CCL17 on Pulmonary Antifungal Responses during Pulmonary Invasive Aspergillosis
Infect. Immun., November 1, 2005; 73(11): 7198 - 7207.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Lundgren, C. Trollmo, A. Edebo, A.-M. Svennerholm, and B. S. Lundin
Helicobacter pylori-Specific CD4+ T Cells Home to and Accumulate in the Human Helicobacter pylori-Infected Gastric Mucosa
Infect. Immun., September 1, 2005; 73(9): 5612 - 5619.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Morimoto, Y. Bian, P. Gao, Y. Yashiro-Ohtani, X.-Y. Zhou, S. Ono, H. Nakahara, M. Kogo, T. Hamaoka, and H. Fujiwara
Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development
J. Leukoc. Biol., September 1, 2005; 78(3): 753 - 761.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ying, B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T. H. Lee, et al.
Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity
J. Immunol., June 15, 2005; 174(12): 8183 - 8190.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. P. Matthews, J. S. Tregoning, A. J. Coyle, T. Hussell, and P. J. M. Openshaw
Role of CCL11 in Eosinophilic Lung Disease during Respiratory Syncytial Virus Infection
J. Virol., February 15, 2005; 79(4): 2050 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Freeman, B.-C. Chiu, V. R. Stolberg, J. Hu, K. Zeibecoglou, N. W. Lukacs, S. A. Lira, S. L. Kunkel, and S. W. Chensue
CCR8 Is Expressed by Antigen-Elicited, IL-10-Producing CD4+CD25+ T Cells, Which Regulate Th2-Mediated Granuloma Formation in Mice
J. Immunol., February 15, 2005; 174(4): 1962 - 1970.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
L. Rivino, M. Messi, D. Jarrossay, A. Lanzavecchia, F. Sallusto, and J. Geginat
Chemokine Receptor Expression Identifies Pre-T Helper (Th)1, Pre-Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells
J. Exp. Med., September 20, 2004; 200(6): 725 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ishida, H. Inagaki, A. Utsunomiya, Y. Takatsuka, H. Komatsu, S. Iida, G. Takeuchi, T. Eimoto, S. Nakamura, and R. Ueda
CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas with Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified
Clin. Cancer Res., August 15, 2004; 10(16): 5494 - 5500.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Cronshaw, C. Owen, Z. Brown, and S. G. Ward
Activation of Phosphoinositide 3-Kinases by the CCR4 Ligand Macrophage-Derived Chemokine Is a Dispensable Signal for T Lymphocyte Chemotaxis
J. Immunol., June 15, 2004; 172(12): 7761 - 7770.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Schaerli, L. Ebert, K. Willimann, A. Blaser, R. S. Roos, P. Loetscher, and B. Moser
A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells
J. Exp. Med., May 3, 2004; 199(9): 1265 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D. K. Hossfeld, and S. Hegewisch-Becker
Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions
Clin. Cancer Res., April 15, 2004; 10(8): 2600 - 2608.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Gutierrez, L. Kremer, A. Zaballos, I. Goya, C. Martinez-A., and G. Marquez
Analysis of Post-translational CCR8 Modifications and Their Influence on Receptor Activity
J. Biol. Chem., April 9, 2004; 279(15): 14726 - 14733.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. S. Haque, J. T. Fallon, J. J. Pan, M. B. Taubman, and P. C. Harpel
Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion
Blood, February 15, 2004; 103(4): 1296 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. N. Francis, M. R. Jacobson, C. M. Lloyd, I. Sabroe, S. R. Durham, and S. J. Till
CXCR1+CD4+ T Cells in Human Allergic Disease
J. Immunol., January 1, 2004; 172(1): 268 - 273.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Ford, T. M. Onami, A. I. Sperling, R. Ahmed, and B. D. Evavold
CD43 Modulates Severity and Onset of Experimental Autoimmune Encephalomyelitis
J. Immunol., December 15, 2003; 171(12): 6527 - 6533.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Christen, D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. A. Oldstone
Among CXCR3 Chemokines, IFN-{gamma}-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-{gamma} (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease
J. Immunol., December 15, 2003; 171(12): 6838 - 6845.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
P. Najarro, H.-J. Lee, J. Fox, J. Pease, and G. L. Smith
Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1
J. Gen. Virol., December 1, 2003; 84(12): 3325 - 3336.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
I. Szabo, M. A. Wetzel, N. Zhang, A. D. Steele, D. E. Kaminsky, C. Chen, L.-Y. Liu-Chen, F. Bednar, E. E. Henderson, O. M. Z. Howard, et al.
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization
J. Leukoc. Biol., December 1, 2003; 74(6): 1074 - 1082.
[Abstract] [Full Text]

Home page
 J. Leukoc. Biol.Home page
D. M. Conroy, L. A. Jopling, C. M. Lloyd, M. R. Hodge, D. P. Andrew, T. J. Williams, J. E. Pease, and I. Sabroe
CCR4 blockade does not inhibit allergic airways inflammation
J. Leukoc. Biol., October 1, 2003; 74(4): 558 - 563.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ishida, A. Utsunomiya, S. Iida, H. Inagaki, Y. Takatsuka, S. Kusumoto, G. Takeuchi, S. Shimizu, M. Ito, H. Komatsu, et al.
Clinical Significance of CCR4 Expression in Adult T-Cell Leukemia/Lymphoma: Its Close Association with Skin Involvement and Unfavorable Outcome
Clin. Cancer Res., September 1, 2003; 9(10): 3625 - 3634.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Senechal, P. de Nadai, N. Ralainirina, A. Scherpereel, H. Vorng, P. Lassalle, A.-B. Tonnel, A. Tsicopoulos, and B. Wallaert
Effect of Diesel on Chemokines and Chemokine Receptors Involved in Helper T Cell Type 1/Type 2 Recruitment in Patients with Asthma
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 215 - 221.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. W. Lukacs, A. L. Miller, and C. M. Hogaboam
Chemokine Receptors in Asthma: Searching for the Correct Immune Targets
J. Immunol., July 1, 2003; 171(1): 11 - 15.
[Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Sasaki, T. Tsuji, T. Jinushi, J. Matsuzaki, T. Sato, K. Chamoto, Y. Togashi, T. Koda, and T. Nishimura
Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets
Int. Immunol., June 1, 2003; 15(6): 701 - 710.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Geginat, A. Lanzavecchia, and F. Sallusto
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines
Blood, June 1, 2003; 101(11): 4260 - 4266.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Bishop and C. M. Lloyd
CC Chemokine Ligand 1 Promotes Recruitment of Eosinophils But Not Th2 Cells During the Development of Allergic Airways Disease
J. Immunol., May 1, 2003; 170(9): 4810 - 4817.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. E. DeVries, H. Cao, J. Wang, L. Xu, A. A. Kelvin, L. Ran, L. A. Chau, J. Madrenas, R. A. Hegele, and D. J. Kelvin
Genomic Organization and Evolution of the CX3CR1/CCR8 Chemokine Receptor Locus
J. Biol. Chem., March 28, 2003; 278(14): 11985 - 11994.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. G. Thebeau and L. A. Morrison
Mechanism of Reduced T-Cell Effector Functions and Class-Switched Antibody Responses to Herpes Simplex Virus Type 2 in the Absence of B7 Costimulation
J. Virol., February 15, 2003; 77(4): 2426 - 2435.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Goya, R. Villares, A. Zaballos, J. Gutierrez, L. Kremer, J.-A. Gonzalo, R. Varona, L. Carramolino, A. Serrano, P. Pallares, et al.
Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease
J. Immunol., February 15, 2003; 170(4): 2138 - 2146.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Krauss-Etschmann, E. Sammler, S. Koletzko, N. Konstantopoulos, D. Aust, B. Gebert, B. Luckow, D. Reinhardt, and D. J. Schendel
Chemokine Receptor 5 Expression in Gastric Mucosa of Helicobacter pylori-Infected and Noninfected Children
Clin. Vaccine Immunol., January 1, 2003; 10(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. Spinetti, G. Bernardini, G. Camarda, A. Mangoni, A. Santoni, M. C. Capogrossi, and M. Napolitano
The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway
J. Leukoc. Biol., January 1, 2003; 73(1): 201 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. D. Chung, F. Kuo, J. Kumer, A. S. Motani, C. E. Lawrence, W. R. Henderson Jr., and C. Venkataraman
CCR8 Is Not Essential for the Development of Inflammation in a Mouse Model of Allergic Airway Disease
J. Immunol., January 1, 2003; 170(1): 581 - 587.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Uchida, H. Suto, C. Ra, H. Ogawa, T. Kobata, and K. Okumura
Preferential expression of Th2-type chemokine and its receptor in atopic dermatitis
Int. Immunol., December 1, 2002; 14(12): 1431 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. D. Campbell, M. J. Stinson, F. E. R. Simons, and K. T. HayGlass
Systemic chemokine and chemokine receptor responses are divergent in allergic versus non-allergic humans
Int. Immunol., November 1, 2002; 14(11): 1255 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
A M A. El-Asrar, S Struyf, S A Al-Kharashi, L Missotten, J Van Damme, and K Geboes
Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis
Br J Ophthalmol, October 1, 2002; 86(10): 1175 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. D'Ambrosio, C. Albanesi, R. Lang, G. Girolomoni, F. Sinigaglia, and C. Laudanna
Quantitative Differences in Chemokine Receptor Engagement Generate Diversity in Integrin-Dependent Lymphocyte Adhesion
J. Immunol., September 1, 2002; 169(5): 2303 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B.-C. Chiu, X.-Z. Shang, V. R. Stolberg, E. Komuniecki, and S. W. Chensue
Population analysis of CD4+ T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses
J. Leukoc. Biol., August 1, 2002; 72(2): 363 - 372.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Glatzel, D. Wesch, F. Schiemann, E. Brandt, O. Janssen, and D. Kabelitz
Patterns of Chemokine Receptor Expression on Peripheral Blood {gamma}{delta} T Lymphocytes: Strong Expression of CCR5 Is a Selective Feature of V{delta}2/V{gamma}9 {gamma}{delta} T Cells
J. Immunol., May 15, 2002; 168(10): 4920 - 4929.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. la Sala, S. Sebastiani, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes
Blood, March 1, 2002; 99(5): 1715 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Jopling, I. Sabroe, D. P. Andrew, T. J. Mitchell, Y. Li, M. R. Hodge, T. J. Williams, and J. E. Pease
The Identification, Characterization, and Distribution of Guinea Pig CCR4 and Epitope Mapping of a Blocking Antibody
J. Biol. Chem., February 22, 2002; 277(9): 6864 - 6873.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Sabroe, C.M. Lloyd, M.K.B. Whyte, S.K. Dower, T.J. Williams, and J.E. Pease
Chemokines, innate and adaptive immunity, and respiratory disease
Eur. Respir. J., February 1, 2002; 19(2): 350 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. F. Lipscomb and B. J. Masten
Dendritic Cells: Immune Regulators in Health and Disease
Physiol Rev, January 1, 2002; 82(1): 97 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. J. Kunkel, J. Boisvert, K. Murphy, M. A. Vierra, M. C. Genovese, A. J. Wardlaw, H. B. Greenberg, M. R. Hodge, L. Wu, E. C. Butcher, et al.
Expression of the Chemokine Receptors CCR4, CCR5, and CXCR3 by Human Tissue-Infiltrating Lymphocytes
Am. J. Pathol., January 1, 2002; 160(1): 347 - 355.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Hase, K. Tani, T. Shimizu, Y. Ohmoto, K. Matsushima, and S. Sone
Increased CCR4 expression in active systemic lupus erythematosus
J. Leukoc. Biol., November 1, 2001; 70(5): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D'AMBROSIO, M. MARIANI, P. PANINA-BORDIGNON, and F. SINIGAGLIA
Chemokines and Their Receptors Guiding T Lymphocyte Recruitment in Lung Inflammation
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1266 - 1275.
[Full Text] [PDF]

Home page
 JEMHome page
A. Iellem, M. Mariani, R. Lang, H. Recalde, P. Panina-Bordignon, F. Sinigaglia, and D. D'Ambrosio
Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells
J. Exp. Med., September 17, 2001; 194(6): 847 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Chtanova, R. A. Kemp, A. P. R. Sutherland, F. Ronchese, and C. R. Mackay
Gene Microarrays Reveal Extensive Differential Gene Expression in Both CD4+ and CD8+ Type 1 and Type 2 T Cells
J. Immunol., September 15, 2001; 167(6): 3057 - 3063.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. R. Luttichau, J. Gerstoft, and T. W. Schwartz
MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8
J. Leukoc. Biol., August 1, 2001; 70(2): 277 - 282.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Ghia, P. Transidico, J. P. Veiga, C. Schaniel, F. Sallusto, K. Matsushima, S. E. Sallan, A. G. Rolink, A. Mantovani, L. M. Nadler, et al.
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells
Blood, August 1, 2001; 98(3): 533 - 540.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton
Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
J. Immunol., July 1, 2001; 167(1): 424 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. C. Berin, M. B. Dwinell, L. Eckmann, and M. F. Kagnoff
Production of MDC/CCL22 by human intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1217 - G1226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Cecilia Berin, L. Eckmann, D. H. Broide, and M. F. Kagnoff
Regulated Production of the T Helper 2-Type T-Cell Chemoattractant TARC by Human Bronchial Epithelial Cells In Vitro and in Human Lung Xenografts
Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 382 - 389.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
F. Katou, H. Ohtani, T. Nakayama, K. Ono, K. Matsushima, A. Saaristo, H. Nagura, O. Yoshie, and K. Motegi
Macrophage-Derived Chemokine (MDC/CCL22) and CCR4 Are Involved in the Formation of T Lymphocyte-Dendritic Cell Clusters in Human Inflamed Skin and Secondary Lymphoid Tissue
Am. J. Pathol., April 1, 2001; 158(4): 1263 - 1270.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. W. Chensue, N. W. Lukacs, T.-Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, et al.
Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice
J. Exp. Med., March 5, 2001; 193(5): 573 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Fahy, H. Porte, S. Senechal, H. Vorng, A. R. McEuen, M. G. Buckley, A. F. Walls, B. Wallaert, A.-B. Tonnel, and A. Tsicopoulos
Chemokine-Induced Cutaneous Inflammatory Cell Infiltration in a Model of Hu-PBMC-SCID Mice Grafted with Human Skin
Am. J. Pathol., March 1, 2001; 158(3): 1053 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Till, L. A. Jopling, P. A. Wachholz, R. L. Robson, S. Qin, D. P. Andrew, L. Wu, J. van Neerven, T. J. Williams, S. R. Durham, et al.
T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4
J. Immunol., February 15, 2001; 166(4): 2303 - 2310.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sebastiani, P. Allavena, C. Albanesi, F. Nasorri, G. Bianchi, C. Traidl, S. Sozzani, G. Girolomoni, and A. Cavani
Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity
J. Immunol., January 15, 2001; 166(2): 996 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Kremer, L. Carramolino, I. Goya, A. Zaballos, J. Gutierrez, M. del Carmen Moreno-Ortiz, C. Martinez-A., and G. Marquez
The Transient Expression of C-C Chemokine Receptor 8 in Thymus Identifies a Thymocyte Subset Committed to Become CD4+ Single-Positive T Cells
J. Immunol., January 1, 2001; 166(1): 218 - 225.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. S. Haque, J. T. Fallon, M. B. Taubman, and P. C. Harpel
The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium
Blood, January 1, 2001; 97(1): 39 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. SINIGAGLIA and D. D'AMBROSIO
Regulation of Helper T Cell Differentiation and Recruitment in Airway Inflammation
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S157 - 160.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Mantovani, P. A. Gray, J. Van Damme, and S. Sozzani
Macrophage-derived chemokine (MDC)
J. Leukoc. Biol., September 1, 2000; 68(3): 400 - 404.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
N. S. Haque, X. Zhang, D. L. French, J. Li, M. Poon, J. T. Fallon, B. R. Gabel, M. B. Taubman, M. Koschinsky, and P. C. Harpel
CC Chemokine I-309 Is the Principal Monocyte Chemoattractant Induced by Apolipoprotein(a) in Human Vascular Endothelial Cells
Circulation, August 15, 2000; 102(7): 786 - 792.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
L. H. Glimcher and K. M. Murphy
Lineage commitment in the immune system: the T helper lymphocyte grows up
Genes & Dev., July 15, 2000; 14(14): 1693 - 1711.
[Full Text]

Home page
 BloodHome page
D. Jones, C. O'Hara, M. D. Kraus, A. R. Perez-Atayde, A. Shahsafaei, L. Wu, and D. M. Dorfman
Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma
Blood, July 15, 2000; 96(2): 685 - 690.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Chizzolini, R. Rezzonico, C. De Luca, D. Burger, and J.-M. Dayer
Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1 (MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes
J. Immunol., June 1, 2000; 164(11): 5952 - 5960.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Y. Chvatchko, A. J. Hoogewerf, A. Meyer, S. Alouani, P. Juillard, R. Buser, F. Conquet, A. E.I. Proudfoot, T. N.C. Wells, and C. A. Power
A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
J. Exp. Med., May 15, 2000; 191(10): 1755 - 1764.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Murdoch and A. Finn
Chemokine receptors and their role in inflammation and infectious diseases
Blood, May 15, 2000; 95(10): 3032 - 3043.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Clissi, D. D'Ambrosio, J. Geginat, L. Colantonio, A. Morrot, N. W. Freshney, J. Downward, F. Sinigaglia, and R. Pardi
Chemokines Fail to Up-Regulate {beta}1 Integrin-Dependent Adhesion in Human Th2 T Lymphocytes
J. Immunol., March 15, 2000; 164(6): 3292 - 3300.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. T. Stine, C. Wood, M. Hill, A. Epp, C. J. Raport, V. L. Schweickart, Y. Endo, T. Sasaki, G. Simmons, C. Boshoff, et al.
KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells
Blood, February 15, 2000; 95(4): 1151 - 1157.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. M. Lloyd, T. Delaney, T. Nguyen, J. Tian, C. Martinez-A, A. J. Coyle, and J.-C. Gutierrez-Ramos
Cc Chemokine Receptor (Ccr)3/Eotaxin Is Followed by Ccr4/Monocyte-Derived Chemokine in Mediating Pulmonary T Helper Lymphocyte Type 2 Recruitment after Serial Antigen Challenge in Vivo
J. Exp. Med., January 17, 2000; 191(2): 265 - 274.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. R. Luttichau, J. Stine, T. P. Boesen, A. H. Johnsen, D. Chantry, J. Gerstoft, and T. W. Schwartz
A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum
J. Exp. Med., January 3, 2000; 191(1): 171 - 180.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Sato, W. A. Kuziel, P. C. Melby, R. L. Reddick, V. Kostecki, W. Zhao, N. Maeda, S. K. Ahuja, and S. S. Ahuja
Defects in the Generation of IFN-{gamma} Are Overcome to Control Infection with Leishmania donovani in CC Chemokine Receptor (CCR) 5-, Macrophage Inflammatory Protein-1{alpha}-, or CCR2-Deficient Mice
J. Immunol., November 15, 1999; 163(10): 5519 - 5525.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Colantonio, A. Iellem, B. Clissi, R. Pardi, L. Rogge, F. Sinigaglia, and D. D'Ambrosio
Upregulation of Integrin alpha 6/beta 1 and Chemokine Receptor CCR1 by Interleukin-12 Promotes the Migration of Human Type 1 Helper T Cells
Blood, November 1, 1999; 94(9): 2981 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. J. Dairaghi, R. A. Fan, B. E. McMaster, M. R. Hanley, and T. J. Schall
HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8. AGONIST AND ANTAGONIST PROFILES OF VIRAL CHEMOKINES
J. Biol. Chem., July 30, 1999; 274(31): 21569 - 21574.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. J. Endres, C. G. Garlisi, H. Xiao, L. Shan, and J. A. Hedrick
The Kaposi's Sarcoma-related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8
J. Exp. Med., June 21, 1999; 189(12): 1993 - 1998.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Ambrosio, D.
Right arrow Articles by Sinigaglia, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Ambrosio, D.
Right arrow Articles by Sinigaglia, F.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS